Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect
Identifieur interne : 000374 ( Istex/Curation ); précédent : 000373; suivant : 000375Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect
Auteurs : Ko Sato [Japon] ; Oshi Watanabe [Japon] ; Suguru Ohmiya [Japon] ; Fumiko Chiba [Japon] ; Masahiro Hayashi [Japon] ; Tamio Suzuki [Japon] ; Kazuyoshi Kawakami [Japon] ; Hidekazu Nishimura [Japon]Source :
- Microbiology and Immunology [ 0385-5600 ] ; 2016-11.
Abstract
Isolation of human parainfluenza virus (HPIV) serotypes 1 and 3 from clinical specimens is not very efficient because of the lack of a cell culture system capable of inducing CPE. In this study, the utility of a melanoma cell line, MNT‐1, that allows HPIV growth and displays CPE was demonstrated. In particularly, the efficiency of isolating HPIV1 and HPIV3 using MNT‐1 was greater than for cell lines conventionally used for HPIV isolation. Our demonstrated efficacy of HPIV1 and HPIV3 isolation with apparent CPE using the MNT‐1 cell culture system has the potential to improve virus isolation from clinical specimens.
Url:
DOI: 10.1111/1348-0421.12446
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000394
Links to Exploration step
ISTEX:15DEC7536283A6A703C82EC18C6C5BFC70F84F32Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect</title>
<author><name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai 983‐8520, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai 983‐8520</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Watanabe, Oshi" sort="Watanabe, Oshi" uniqKey="Watanabe O" first="Oshi" last="Watanabe">Oshi Watanabe</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ohmiya, Suguru" sort="Ohmiya, Suguru" uniqKey="Ohmiya S" first="Suguru" last="Ohmiya">Suguru Ohmiya</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chiba, Fumiko" sort="Chiba, Fumiko" uniqKey="Chiba F" first="Fumiko" last="Chiba">Fumiko Chiba</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hayashi, Masahiro" sort="Hayashi, Masahiro" uniqKey="Hayashi M" first="Masahiro" last="Hayashi">Masahiro Hayashi</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Suzuki, Tamio" sort="Suzuki, Tamio" uniqKey="Suzuki T" first="Tamio" last="Suzuki">Tamio Suzuki</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kawakami, Kazuyoshi" sort="Kawakami, Kazuyoshi" uniqKey="Kawakami K" first="Kazuyoshi" last="Kawakami">Kazuyoshi Kawakami</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: hide-nishimura@mte.biglobe.ne.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
<affiliation><mods:affiliation>Hidekazu Nishimura, Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai, Miyagi 983‐8520, Japan. Tel: +81 22 293 1173; fax: +81 22 293 1173; email:</mods:affiliation>
<wicri:noCountry code="subField">email:</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: hide-nishimura@mte.biglobe.ne.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:15DEC7536283A6A703C82EC18C6C5BFC70F84F32</idno>
<date when="2016" year="2016">2016</date>
<idno type="doi">10.1111/1348-0421.12446</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7QBR3RZ0-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000394</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000394</idno>
<idno type="wicri:Area/Istex/Curation">000374</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect</title>
<author><name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai 983‐8520, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai 983‐8520</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Watanabe, Oshi" sort="Watanabe, Oshi" uniqKey="Watanabe O" first="Oshi" last="Watanabe">Oshi Watanabe</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ohmiya, Suguru" sort="Ohmiya, Suguru" uniqKey="Ohmiya S" first="Suguru" last="Ohmiya">Suguru Ohmiya</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chiba, Fumiko" sort="Chiba, Fumiko" uniqKey="Chiba F" first="Fumiko" last="Chiba">Fumiko Chiba</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hayashi, Masahiro" sort="Hayashi, Masahiro" uniqKey="Hayashi M" first="Masahiro" last="Hayashi">Masahiro Hayashi</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Suzuki, Tamio" sort="Suzuki, Tamio" uniqKey="Suzuki T" first="Tamio" last="Suzuki">Tamio Suzuki</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kawakami, Kazuyoshi" sort="Kawakami, Kazuyoshi" uniqKey="Kawakami K" first="Kazuyoshi" last="Kawakami">Kazuyoshi Kawakami</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<affiliation wicri:level="1"><mods:affiliation>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: hide-nishimura@mte.biglobe.ne.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
<affiliation><mods:affiliation>Hidekazu Nishimura, Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai, Miyagi 983‐8520, Japan. Tel: +81 22 293 1173; fax: +81 22 293 1173; email:</mods:affiliation>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: hide-nishimura@mte.biglobe.ne.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Microbiology and Immunology</title>
<title level="j" type="alt">MICROBIOLOGY AND IMMUNOLOGY</title>
<idno type="ISSN">0385-5600</idno>
<idno type="eISSN">1348-0421</idno>
<imprint><biblScope unit="vol">60</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="801">801</biblScope>
<biblScope unit="page" to="805">805</biblScope>
<biblScope unit="page-count">5</biblScope>
<date type="published" when="2016-11">2016-11</date>
</imprint>
<idno type="ISSN">0385-5600</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0385-5600</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Isolation of human parainfluenza virus (HPIV) serotypes 1 and 3 from clinical specimens is not very efficient because of the lack of a cell culture system capable of inducing CPE. In this study, the utility of a melanoma cell line, MNT‐1, that allows HPIV growth and displays CPE was demonstrated. In particularly, the efficiency of isolating HPIV1 and HPIV3 using MNT‐1 was greater than for cell lines conventionally used for HPIV isolation. Our demonstrated efficacy of HPIV1 and HPIV3 isolation with apparent CPE using the MNT‐1 cell culture system has the potential to improve virus isolation from clinical specimens.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000374 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000374 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:15DEC7536283A6A703C82EC18C6C5BFC70F84F32 |texte= Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |